Arca
Skip to content

Xlite

System, X-Ray, Mobile. 510(k) K260236, from Gemss Healthcare Co., Ltd. (Paju-Si, KR). Product code IZL, class 2.

As of Nov 17, 2026, K260236 is an FDA 510(k) held by Gemss Healthcare Co., Ltd., substantially equivalent on Aug 3, 2026 after 189 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Aug 3, 2026
  • Review time: 189 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The XLITE is a mobile diagnostic X-ray system intended for stand-mounted use by qualified and trained healthcare professionals to produce diagnostic radiographic images of the extremities in adult patients. The device is intended for extremity imaging only. The device is not intended for mammography.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other IZL Clearances

The newest 510(k)s for the same product code; their median review was 166 days; see every IZL device

Record

Type
Traditional, third-party review
Received
Jan 26, 2026
Review panel
Radiology
Regulation
21 CFR 892.1720

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.